FAT1 and mantle cell lymphoma: We observed that in MCL BM, the non-malignant pro-/pre-B cells were characterized by SOX4 expression, whereas the clinically defined blastoid MCL case (patient 1) was marked by a subset of cells expressing both SOX11 and SOX4 together with FAT1.